Why the study?
Does implantation of an Occlutech Atrial Flow Regulator improve symptoms in a young child with drug-resistant idiopathic pulmonary hypertension?
Does implantation of an Occlutech Atrial Flow Regulator improve symptoms in a young child with drug-resistant idiopathic pulmonary hypertension?
Implantation of an atrial flow regulator may provide symptom relief in children with drug-resistant idiopathic pulmonary hypertension.
May support symptom relief with atrial flow regulator in pediatric drug-resistant pulmonary hypertension; leaves open need for controlled trials.
This case describes the successful implantation of an Occlutech Atrial Flow Regulator in a young child with idiopathic pulmonary hypertension and recurrent syncope despite targeted combination therapy, with subsequent relief of symptoms.
No takes yet. Share an insight, caveat, or question.
Vanhie et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: